Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · December 03, 2022

mTOR Inhibition in Patients With STEMI

Journal of the American College of Cardiology


Additional Info

Journal of the American College of Cardiology
Mammalian Target of Rapamycin Inhibition in Patients With ST-Segment Elevation Myocardial Infarction
J Am Coll Cardiol 2022 Nov 08;80(19)1802-1814, BE Stähli, R Klingenberg, D Heg, M Branca, R Manka, I Kapos, O Müggler, A Denegri, R Kesterke, F Berger, J Stehli, A Candreva, A von Eckardstein, D Carballo, C Hamm, U Landmesser, F Mach, T Moccetti, C Jung, M Kelm, T Münzel, G Pedrazzini, L Räber, S Windecker, C Templin, CM Matter, TF Lüscher, F Ruschitzka

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading